We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Diabetes and COVID‐19.
- Authors
Bloomgarden, Zachary T.
- Abstract
After the recognition in December 2019 of a cluster of patients with pneumonia of unknown cause in Wuhan caused by the novel coronavirus, CoV-19,[1] China and the world have faced the extraordinary challenge of a previously unrecognized viral illness with high infectivity.[2] Every year, millions of persons (5%-15% of the world's population) contract influenza,[[3]] causing between 300 000 and 600 000 excess respiratory deaths.[5] In China alone, recent estimates put the annual influenza-associated mortality rate at more than 88 000 persons,[6] likely in excess of any potential outcome of coronavirus disease 2019 (COVID-19). Global seasonal influenza-associated mortality collaborator network estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection.
- Subjects
COVID-19; MIDDLE East respiratory syndrome; SARS disease; INFLUENZA; DIABETES; CD26 antigen; H7N9 Influenza
- Publication
Journal of Diabetes, 2020, Vol 12, Issue 4, p347
- ISSN
1753-0393
- Publication type
Article
- DOI
10.1111/1753-0407.13027